Publicação: Infliximab-induced psoriasis during therapy for Crohn's disease
dc.contributor.author | Steinwurz, Flavio | |
dc.contributor.author | Denadai, Rafael [UNESP] | |
dc.contributor.author | Saad-Hossne, Rogerio [UNESP] | |
dc.contributor.author | Queiroz, Maria Luiza | |
dc.contributor.author | Teixeira, Fabio Vieira [UNESP] | |
dc.contributor.author | Romiti, Ricardo | |
dc.contributor.institution | Hosp Israelita Albert Einstein | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.date.accessioned | 2014-05-20T13:32:37Z | |
dc.date.available | 2014-05-20T13:32:37Z | |
dc.date.issued | 2012-06-01 | |
dc.description.abstract | Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon. (C) 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved. | en |
dc.description.affiliation | Hosp Israelita Albert Einstein, Unit Inflammatory Bowel Dis, BR-05652900 São Paulo, Brazil | |
dc.description.affiliation | Univ State São Paulo UNESP, Botucatu Med Sch, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil | |
dc.description.affiliation | State Univ São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil | |
dc.description.affiliation | Univ State São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil | |
dc.description.affiliation | Univ São Paulo, Sch Med Sci, Dept Dermatol, São Paulo, Brazil | |
dc.description.affiliationUnesp | Univ State São Paulo UNESP, Botucatu Med Sch, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil | |
dc.description.affiliationUnesp | State Univ São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil | |
dc.description.affiliationUnesp | Univ State São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil | |
dc.format.extent | 610-616 | |
dc.identifier | http://dx.doi.org/10.1016/j.crohns.2011.12.007 | |
dc.identifier.citation | Journal of Crohns & Colitis. Amsterdam: Elsevier B.V., v. 6, n. 5, p. 610-616, 2012. | |
dc.identifier.doi | 10.1016/j.crohns.2011.12.007 | |
dc.identifier.issn | 1873-9946 | |
dc.identifier.uri | http://hdl.handle.net/11449/11130 | |
dc.identifier.wos | WOS:000304689700016 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Journal of Crohns & Colitis | |
dc.relation.ispartofjcr | 6.637 | |
dc.relation.ispartofsjr | 2,728 | |
dc.rights.accessRights | Acesso restrito | |
dc.source | Web of Science | |
dc.subject | Biological therapy | en |
dc.subject | Crohn's disease | en |
dc.subject | Infliximab | en |
dc.subject | Psoriasis | en |
dc.subject | Tumor necrosis factor-alpha inhibitors | en |
dc.title | Infliximab-induced psoriasis during therapy for Crohn's disease | en |
dc.type | Artigo | |
dcterms.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dcterms.rightsHolder | Elsevier B.V. | |
dspace.entity.type | Publication | |
unesp.author.orcid | 0000-0003-0525-3480[2] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |
unesp.department | Cirurgia e Ortopedia - FMB | pt |
Arquivos
Licença do Pacote
1 - 2 de 2
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: